Many Approved Drugs Have Bioactive Analogs With Different Target Annotations

Abstract

ABSTRACT. Close structural relationships between approved drugs and bioactive compounds were systematically assessed using matched molecular pairs. For structural analogs of drugs, target information was assembled from ChEMBL and compared to drug targets reported in DrugBank. For many drugs, multiple analogs were identified that were active against different targets. Some of these additional targets were closely related to known drug targets while others were not. Surprising discrepancies between reported drug targets and targets of close structural analogs were often observed. On one hand, the results suggest that hypotheses concerning alternative drug targets can often be formulated on the basis of close structural relationships to bioactive compounds that are easily detectable. It is conceivable that such obvious structure-target relationships are frequently not considered (or might be overlooked) when compounds are developed with a focus on a primary target and a few related (or undesired) ones. On the other hand, our findings also raise questions concerning database content and drug repositioning efforts.

Molecular Mechanism of Action of Antimalarial Benzoisothiazolones: Species-Selective Inhibitors of the Plasmodium spp. MEP Pathway enzyme, IspD

“…Indeed, aspirin, also a covalent modifier, is one of the most widely used drug in the world. The polypharmacology of bioactive molecules3233 and approved drugs34 has similarly been studied and is consistent with the concept that safe and effective drugs are invariably active at many targets. One such study calculates that, on average, approved therapeutics are active against approximately seven different molecular targets35.…”

Structural and Activity Profile Relationships Between Drug Scaffolds

“…In addition to the scaffold concept and the generation of activity profiles, the use of MMP analysis (including standard and retrosynthetic MMPs) for the systematic assessment of structural relationships has been a central aspect of our study. Scaffold mapping and MMP analysis have made frequent contributions to drug discovery, for example, through the identification of novel bioactive scaffolds along structural decomposition pathways (6,7) or the generation of additional target hypotheses for drugs through systematic exploration of MMP relationships with bioactive analogs (35).…”

Quantum Tunnelling for Hawking Radiation from Both Static and Dynamic Black Holes

“…Further, the above analysis of tunnelling approach remains incomplete unless effects of self gravitation and back reaction are taken into account. But unfortunately, no general approach to account for the above effects are there in the literature-only few results are available for some known BH solutions [26][27][28][29].…”